XYLOCAINE OINTMENT 5%
Manufacturer Details
ASTRA ZENECA
AstraZeneca Pharma India Ltd
Bellary Road Hebbal
Bangalore 560024
Compositions:
Ligmocaine 5% ointment,
|
Strength
|
Rate
|
Packing Style
|
|
5%
|
41.30
|
20g ointment
|
List of Related Indications:
List Of Drugs:
Indication Type Description:
Drug Interaction:
None reported
Indication:
Infiltraion block
FIXED DOSE COMBINATIONS APPROVED BY DCG(I)
FROM JANUARY 1961 TILL NOVEMBER 2014
Name of Drug Indication Date of Approval
1.Lignocaine 50mg + Sep-1978
Aluminium hydroxide 300mg +
Magnesium Hydroxide 100mg +
Activated dimethicone 20 NF 50mg
tablets and 5ml suspension
2.Lignocaine base 2% + 18-06-1996
Silver Sulphadiazine 1% +
Chlorhexidine gluconate 0.02% cream
Temporary pain relief & to prevent infection in cuts
& burn, wound, nicks, scrapes, scratches abersion
herper zoster , bed sores
3.PVP/VA resin 5%+ Sep 1977
Benzalkonium chloride 0.10% +
Lignocaine hcl 0.25% +
D-panthanol DAB -7 DDR 2%
aerosol pack of 85gm
Adverse Reaction:
Dizziness visual disturbances tremor, respiratory depression bradycardia hypotension
Contra-Indications:
AV block conduction disturbances cardiac decompensation Special precautions: Hepatic or renal insufficiency Epilepsy Traumatized mucosa severe shock Heart block Monior for familal malignant hyperthermia
Dosages/ Overdosage Etc:
Infiltration block
Dosage-
Max 200mg
